现代肿瘤医学
現代腫瘤醫學
현대종류의학
JOURNAL OF MODERN ONCOLOGY
2014年
5期
980-984
,共5页
曹伟%宋鉴清%吕昊玥%赵军莉%刘树立%于贵博%刘江
曹偉%宋鑒清%呂昊玥%趙軍莉%劉樹立%于貴博%劉江
조위%송감청%려호모%조군리%류수립%우귀박%류강
胃癌%T-cadherin%VEGF%MVD
胃癌%T-cadherin%VEGF%MVD
위암%T-cadherin%VEGF%MVD
gastric cancer%T - cadherin%VEGF%MVD
目的:探讨 T - cadherin 在胃癌组织中表达及其与 VEGF、MVD 之间的关系。方法:采用免疫组化 SP 法对80例胃癌组织及癌旁正常胃组织的 T - cadherin、血管内皮生长因子( Vascular endothelial growth factor,VEGF)和 CD34的表达情况进行检测。结果:T - cadherin 主要在胃癌细胞膜上表达,阳性率为45.0%(36/80),而癌旁正常胃组织中 T - cadherin 阳性率为62.5%(50/80),两者比较差异有统计学意义(P=0.026)。VEGF 在癌旁正常细胞阳性率为28.75%,在胃癌中表达阳性率为71.25%,差异有统计学意义(P=0.000)。CD34阳性细胞着色部位主要是血管内皮细胞的胞膜和胞浆,胃癌中标记的微血管明显多于正常组织(54.96±7.28/ ePF vs 27.50±6.10/ ePF,P ﹤0.001)。T - cadherin 和 VEGF 蛋白表达呈负相关( P=0.001);T - cadherin 阳性组的 MVD 值明显低于阴性低表达组(P ﹤0.001). T - cadherin 、VEGF、CD343种蛋白在胃癌中的阳性表达与患者性别和年龄、肿瘤大小均无关(P ﹥0.05),但与组织分化程度、淋巴结转移及 PTNM 分期显著相关(P ﹤0.05)。结论:T - cadherin 的异常表达可以作为临床评价胃癌诊断、指导治疗及判断预后的辅助指标之一。
目的:探討 T - cadherin 在胃癌組織中錶達及其與 VEGF、MVD 之間的關繫。方法:採用免疫組化 SP 法對80例胃癌組織及癌徬正常胃組織的 T - cadherin、血管內皮生長因子( Vascular endothelial growth factor,VEGF)和 CD34的錶達情況進行檢測。結果:T - cadherin 主要在胃癌細胞膜上錶達,暘性率為45.0%(36/80),而癌徬正常胃組織中 T - cadherin 暘性率為62.5%(50/80),兩者比較差異有統計學意義(P=0.026)。VEGF 在癌徬正常細胞暘性率為28.75%,在胃癌中錶達暘性率為71.25%,差異有統計學意義(P=0.000)。CD34暘性細胞著色部位主要是血管內皮細胞的胞膜和胞漿,胃癌中標記的微血管明顯多于正常組織(54.96±7.28/ ePF vs 27.50±6.10/ ePF,P ﹤0.001)。T - cadherin 和 VEGF 蛋白錶達呈負相關( P=0.001);T - cadherin 暘性組的 MVD 值明顯低于陰性低錶達組(P ﹤0.001). T - cadherin 、VEGF、CD343種蛋白在胃癌中的暘性錶達與患者性彆和年齡、腫瘤大小均無關(P ﹥0.05),但與組織分化程度、淋巴結轉移及 PTNM 分期顯著相關(P ﹤0.05)。結論:T - cadherin 的異常錶達可以作為臨床評價胃癌診斷、指導治療及判斷預後的輔助指標之一。
목적:탐토 T - cadherin 재위암조직중표체급기여 VEGF、MVD 지간적관계。방법:채용면역조화 SP 법대80례위암조직급암방정상위조직적 T - cadherin、혈관내피생장인자( Vascular endothelial growth factor,VEGF)화 CD34적표체정황진행검측。결과:T - cadherin 주요재위암세포막상표체,양성솔위45.0%(36/80),이암방정상위조직중 T - cadherin 양성솔위62.5%(50/80),량자비교차이유통계학의의(P=0.026)。VEGF 재암방정상세포양성솔위28.75%,재위암중표체양성솔위71.25%,차이유통계학의의(P=0.000)。CD34양성세포착색부위주요시혈관내피세포적포막화포장,위암중표기적미혈관명현다우정상조직(54.96±7.28/ ePF vs 27.50±6.10/ ePF,P ﹤0.001)。T - cadherin 화 VEGF 단백표체정부상관( P=0.001);T - cadherin 양성조적 MVD 치명현저우음성저표체조(P ﹤0.001). T - cadherin 、VEGF、CD343충단백재위암중적양성표체여환자성별화년령、종류대소균무관(P ﹥0.05),단여조직분화정도、림파결전이급 PTNM 분기현저상관(P ﹤0.05)。결론:T - cadherin 적이상표체가이작위림상평개위암진단、지도치료급판단예후적보조지표지일。
Objective:To discuss T - cadherin exPression in gastric cancer and the relationshiP between VEGF, MVD. Methods:Using immunohistochemical SP method to test the exPression of T - cadherin,vascular endothelial growth factor(VEGF)and CD34 in 80 cases of gastric cancer tissue and normal gastric tissue adjacent to carcinoma. Results:T - cadherin exPressied in the gastric cancer cell membrane,Positive rate was 45. 0%(36 / 80),while in normal gastric tissues adjacent to carcinoma T - cadherin Positive rate was 62. 5%(50 / 80,P = 0. 026). VEGF in normal cells adjacent to carcinoma Positive rate was 28. 75% ,the exPression Positive rate was 71. 25% in cancer of the stomach(P = 0. 000). CD34 Positive cells mark of caPillaries in gastric cancer significantly more than the normal tissue(54. 96 ± 7. 28 / ePF vs 27. 50 ± 6. 10 / ePF,P ﹤ 0. 001). T - cadherin was negatively correlated with VEGF Protein exPression(P ﹤ 0. 001). The MVD value of T - cadherin Positive grouP was obviously lower than negative low exPression grouP(P ﹤ 0. 001). The T - cadherin,VEGF and CD34 in gastric cancer Patients were not correlatad gender,age,size,( P ﹥ 0 . 05 ),but with tissue differentiation degree and lymPh node metastasis and PTNM stage (P ﹤ 0. 05). Conclusion:T - cadherin abnormal exPression can be used for gastric cancer diagnosis,treatment and Prognosis evaluation.